Ann E. Tollefson

5.4k total citations
81 papers, 4.2k citations indexed

About

Ann E. Tollefson is a scholar working on Genetics, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Ann E. Tollefson has authored 81 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Genetics, 46 papers in Molecular Biology and 21 papers in Infectious Diseases. Recurrent topics in Ann E. Tollefson's work include Virus-based gene therapy research (72 papers), Viral Infectious Diseases and Gene Expression in Insects (25 papers) and CAR-T cell therapy research (19 papers). Ann E. Tollefson is often cited by papers focused on Virus-based gene therapy research (72 papers), Viral Infectious Diseases and Gene Expression in Insects (25 papers) and CAR-T cell therapy research (19 papers). Ann E. Tollefson collaborates with scholars based in United States, Spain and China. Ann E. Tollefson's co-authors include William S.M. Wold, Károly Tóth, Terry Hermiston, Konstantin Doronin, Mohan Kuppuswamy, L R Gooding, Abraham Scaria, Péter Krajcsi, Drew L. Lichtenstein and Jacqueline F. Spencer and has published in prestigious journals such as Nature, Cell and The Journal of Immunology.

In The Last Decade

Ann E. Tollefson

80 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann E. Tollefson United States 37 3.2k 2.6k 1.3k 864 683 81 4.2k
Terry Hermiston United States 33 2.7k 0.9× 2.4k 0.9× 1.5k 1.1× 503 0.6× 751 1.1× 61 3.8k
Thomas Dobner Germany 46 2.9k 0.9× 3.7k 1.5× 1.6k 1.2× 513 0.6× 745 1.1× 137 5.4k
Volker Sandig Germany 29 1.4k 0.4× 2.5k 1.0× 557 0.4× 494 0.6× 375 0.5× 95 3.4k
Gary Ketner United States 30 2.0k 0.6× 2.1k 0.8× 810 0.6× 507 0.6× 365 0.5× 56 3.0k
Göran Akusjärvi Sweden 41 3.1k 1.0× 4.4k 1.7× 815 0.6× 820 0.9× 440 0.6× 129 5.5k
Jean‐Simon Diallo Canada 29 1.7k 0.5× 1.2k 0.5× 1.5k 1.2× 326 0.4× 308 0.5× 78 2.8k
Adam Sampson-Johannes United States 15 2.4k 0.8× 2.3k 0.9× 1.8k 1.4× 339 0.4× 289 0.4× 18 4.0k
Nanhai G. Chen United States 34 2.2k 0.7× 1.3k 0.5× 1.5k 1.2× 296 0.3× 887 1.3× 97 3.5k
Matthew Coffey United States 22 1.6k 0.5× 842 0.3× 848 0.7× 781 0.9× 190 0.3× 45 2.1k
Hans-Gerhard Burgert Germany 30 1.3k 0.4× 1.0k 0.4× 542 0.4× 369 0.4× 830 1.2× 49 2.7k

Countries citing papers authored by Ann E. Tollefson

Since Specialization
Citations

This map shows the geographic impact of Ann E. Tollefson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Tollefson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Tollefson more than expected).

Fields of papers citing papers by Ann E. Tollefson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Tollefson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Tollefson. The network helps show where Ann E. Tollefson may publish in the future.

Co-authorship network of co-authors of Ann E. Tollefson

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Tollefson. A scholar is included among the top collaborators of Ann E. Tollefson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Tollefson. Ann E. Tollefson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tollefson, Ann E., Nicolas Landrein, Vincent Roy, et al.. (2025). LAVR-289, an Orally Bioavailable Inhibitor of Adenovirus Replication In Vitro and In Vivo. ACS Infectious Diseases. 11(6). 1416–1423.
2.
3.
4.
Zhang, Heng, Jing Li, Károly Tóth, et al.. (2023). Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration. Bioorganic & Medicinal Chemistry. 96. 117531–117531. 4 indexed citations
5.
Jessup, J. Milburn, Mohamed Kabbout, Nikolay Korokhov, et al.. (2019). Adenovirus and Oxaliplatin cooperate as agnostic sensitizers for immunogenic cell death in colorectal carcinoma. Human Vaccines & Immunotherapeutics. 16(3). 636–644. 9 indexed citations
6.
Tóth, Károly, Ann E. Tollefson, Jacqueline F. Spencer, Baoling Ying, & William S.M. Wold. (2017). Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds. Antiviral Research. 146. 121–129. 9 indexed citations
7.
Tóth, Károly, Baoling Ying, Jacqueline F. Spencer, et al.. (2015). STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control. PLoS Pathogens. 11(8). e1005084–e1005084. 43 indexed citations
8.
Young, Bessie A., Jacqueline F. Spencer, Baoling Ying, et al.. (2013). The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors. Cancer Gene Therapy. 20(9). 521–530. 17 indexed citations
9.
Ying, Baoling, Károly Tóth, Jacqueline F. Spencer, et al.. (2009). INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. Cancer Gene Therapy. 16(8). 625–637. 47 indexed citations
10.
Wold, William S.M. & Ann E. Tollefson. (2007). Adenoviruses, ad vectors, quantitation, and animal models. Humana Press eBooks. 1 indexed citations
11.
Tollefson, Ann E., Mohan Kuppuswamy, Elena V. Shashkova, Konstantin Doronin, & William S.M. Wold. (2007). Preparation and Titration of CsCl-Banded Adenovirus Stocks. Humana Press eBooks. 130. 223–236. 69 indexed citations
12.
Kanj, Souha S., Lina Kozhaya, Talal Mousallem, et al.. (2005). Ceramide regulates SR protein phosphorylation during adenoviral infection. Virology. 345(1). 280–289. 20 indexed citations
13.
Lichtenstein, Drew L., Károly Tóth, Konstantin Doronin, Ann E. Tollefson, & William S.M. Wold. (2004). FUNCTIONS AND MECHANISMS OF ACTION OF THE ADENOVIRUS E3 PROTEINS. International Reviews of Immunology. 23(1-2). 75–111. 144 indexed citations
14.
Tóth, Károly, Mohan Kuppuswamy, Konstantin Doronin, et al.. (2002). Construction and Characterization of E1-Minus Replication-Defective Adenovirus Vectors that Express E3 Proteins from the E1 Region. Virology. 301(1). 99–108. 7 indexed citations
15.
Kladney, Raleigh D., Ann E. Tollefson, William S.M. Wold, & Claus J. Fimmel. (2002). Upregulation of the Golgi Protein GP73 by Adenovirus Infection Requires the E1A CtBP Interaction Domain. Virology. 301(2). 236–246. 30 indexed citations
16.
Habib, Nagy, Ragai R. Mitry, Prem Seth, et al.. (2002). Adenovirus replication–competent vectors (KD1, KD3) complement the cytotoxicity and transgene expression from replication-defective vectors (Ad-GFP, Ad-Luc). Cancer Gene Therapy. 9(8). 651–654. 17 indexed citations
17.
Wold, William S.M., Konstantin Doronin, Károly Tóth, et al.. (1999). Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Current Opinion in Immunology. 11(4). 380–386. 151 indexed citations
18.
Wold, William S.M., Ann E. Tollefson, & Terry Hermiston. (1995). E3 Transcription Unit of Adenovirus. Current topics in microbiology and immunology. 199 ( Pt 1). 237–274. 89 indexed citations
19.
Wold, William S.M., Terry Hermiston, & Ann E. Tollefson. (1994). Adenovirus proteins that subvert host defenses. Trends in Microbiology. 2(11). 437–443. 75 indexed citations
20.
Gooding, L R, Lynne W. Elmore, Ann E. Tollefson, Helen Brady, & William S.M. Wold. (1988). A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell. 53(3). 341–346. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terry Hermiston Breakdown of academic impact, for papers by Thomas Dobner Breakdown of academic impact, for papers by Volker Sandig Breakdown of academic impact, for papers by Gary Ketner Breakdown of academic impact, for papers by Göran Akusjärvi Breakdown of academic impact, for papers by Jean‐Simon Diallo Breakdown of academic impact, for papers by Adam Sampson-Johannes Breakdown of academic impact, for papers by Nanhai G. Chen Breakdown of academic impact, for papers by Matthew Coffey Breakdown of academic impact, for papers by Hans-Gerhard Burgert
Rankless by CCL
2026